ANZ

DZS Completes Divestiture of Asia Business

Retrieved on: 
Friday, April 5, 2024

On Jan. 5, 2024, DZS signed a definitive agreement to sell its Asia operations to DNI, for $48 million (including the elimination of $43 million in debt).

Key Points: 
  • On Jan. 5, 2024, DZS signed a definitive agreement to sell its Asia operations to DNI, for $48 million (including the elimination of $43 million in debt).
  • With the sale of the Asia business, DZS is expected to be better positioned to achieve higher blended margins, and with a higher percentage of its total revenue resulting from recurring and reoccurring licenses related to its software-centric solutions.
  • DZS believes that service providers are deemphasizing closed, proprietary and high security-risk solutions and are increasingly adopting open, standards-based, software-defined solutions.
  • The notification letter has no immediate effect on the listing or trading of DZS common stock on the Nasdaq Capital Market.

Searce Wins 2024 Google Cloud Sales Partner of the Year for UKI

Retrieved on: 
Tuesday, April 9, 2024

Searce , a modern technology consulting firm that empowers clients to futurify their businesses, has been announced as the winner of the 2024 Google Cloud Sales Partner of the Year award for the UK and Ireland (UKI).

Key Points: 
  • Searce , a modern technology consulting firm that empowers clients to futurify their businesses, has been announced as the winner of the 2024 Google Cloud Sales Partner of the Year award for the UK and Ireland (UKI).
  • This recognition by Google Cloud reinforces Searce’s strong commitment to digitally transform organisations worldwide by offering advanced professional services around Cloud, Data, Analytics, and AI-led transformation.
  • “We are honored to receive the 2024 Google Cloud Sales Partner of the Year award for UKI,” said Julian Mulhare – Managing Director, EMEA, Searce.
  • “Google Cloud's Partner Awards celebrate the transformative impact and value partners have delivered for customers," said Kevin Ichhpurani, Corporate Vice President, Global Ecosystem and Channels at Google Cloud.

Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand

Retrieved on: 
Monday, March 18, 2024

RESEARCH TRIANGLE PARK, N.C. and UXBRIDGE, United Kingdom, March 17, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, and Norgine, a leading European specialist pharmaceutical company, today announced an exclusive licensing agreement under which Norgine will commercialize PEDMARQSI® in Europe, Australia and New Zealand. PEDMARQSI is the first and only approved therapy in the EU and U.K. for the prevention of ototoxicity (hearing loss) induced by cisplatin chemotherapy in patients 1 month to

Key Points: 
  • Norgine will be responsible for all commercialization activities in the licensed territories and will hold all marketing authorizations in the licensed territories.
  • It is estimated that more than 5,000 pediatric patients annually are eligible for platinum-based chemotherapy in Europe.
  • PEDMARQSI was granted EU marketing authorization by the European Commission in June 2023, and received UK approval from the MHRA in October 2023.
  • The studies compared PEDMARQSI plus cisplatin-based regimens to cisplatin-based regimens alone for the reduction of cisplatin-induced hearing loss in pediatric patients.

Celonis Appoints First Country Leader for Australia & New Zealand

Retrieved on: 
Thursday, April 4, 2024

Celonis , the global leader in Process Mining , today announced it has appointed Pascal Coubard to lead its presence in Australia and New Zealand (ANZ), expanding the company’s burgeoning footprint in the Asia-Pacific (APAC) region.

Key Points: 
  • Celonis , the global leader in Process Mining , today announced it has appointed Pascal Coubard to lead its presence in Australia and New Zealand (ANZ), expanding the company’s burgeoning footprint in the Asia-Pacific (APAC) region.
  • Pascal is a seasoned go-to-market leader with more than 25 years experience in the global IT industry.
  • “Bringing Pascal onto the team represents an exciting milestone for us,” said Philippe Mathieu, senior vice president EMEA and APAC, Celonis.
  • “He is the right person to position Celonis for long term success in ANZ and the wider APAC region.

Cloudflare Channel and Alliance Business Revenue Accelerates 174% Over Two Years and Expands with Additional Paths to Revenue, Program Awarded 5-Stars by CRN

Retrieved on: 
Tuesday, March 26, 2024

The company’s recently launched Cloudflare PowerUP Partner Program provides additional, clear paths to revenue for its channel partners globally.

Key Points: 
  • The company’s recently launched Cloudflare PowerUP Partner Program provides additional, clear paths to revenue for its channel partners globally.
  • The Program expansion comes as Cloudflare’s partnerships and alliances have been delivering strong results to joint customers across sectors worldwide.
  • Cloudflare’s connectivity cloud is the digital core for businesses to transform how they connect, protect, and build in their digital environments.
  • Becoming authorized as a partner includes accreditations and exclusive sessions, starting with upleveling skills from Cloudflare University, to customized training.

Dialpad Earns 2024 CRN® Partner Program Guide Recognition

Retrieved on: 
Monday, March 25, 2024

– the industry-leading Ai-Powered Customer Intelligence Platform – today announced that it has been honored by CRN®, a brand of The Channel Company , with inclusion in its 2024 Partner Program Guide.

Key Points: 
  • – the industry-leading Ai-Powered Customer Intelligence Platform – today announced that it has been honored by CRN®, a brand of The Channel Company , with inclusion in its 2024 Partner Program Guide.
  • “Being named to the CRN Partner Program Guide is a tremendous acknowledgment of Dialpad’s achievements and unparalleled channel momentum,” said Kane.
  • For the 2024 Partner Program Guide, CRN evaluated vendors based on program requirements and offerings such as partner training and education, pre- and post-sales support, marketing programs and resources, technical support, and communication.
  • With CRN’s 2024 Partner Program Guide, solution providers can access deep insights into the unique strengths of each partner program and the vendors who demonstrate dedication to their partner community.”
    Dialpad’s partner program and Kane received several additional accolades over the last year including Kane’s recognition on the 2024 CRN® Channel Chief for the third consecutive year and a five-star designation as a part of CRN’s 2023 Partner Program Guide.

Swift Sets Industry Up for Seamless Introduction of CBDCs for Cross-Border Transactions as Interlinking Solution Finds More Use Cases

Retrieved on: 
Monday, March 25, 2024

Swift’s solution has already been shown to enable cross-border transfers and connect CBDCs on different networks with each other, as well as with fiat currencies.

Key Points: 
  • Swift’s solution has already been shown to enable cross-border transfers and connect CBDCs on different networks with each other, as well as with fiat currencies.
  • The second phase of sandbox testing went further, exploring more complex use cases, using Swift’s solution to connect and orchestrate transactions across simulated digital trade and tokenised asset and FX networks, alongside CBDCs for payments.
  • Swift now plans to extend its solution to support a wider range of emerging digital networks in addition to CBDCs, such as platforms for tokenised deposits.
  • This will help to facilitate access and usage of CBDCs in the new complex world of digital payments.

eSentire Launches New Threat Intelligence Offering, Surpassing Leading Commercial Threat Feeds With a 99% True Positive Rate for its Indicators of Compromise (IOCs)

Retrieved on: 
Tuesday, March 19, 2024

eSentire Threat Intelligence provides mid-market and enterprise organizations with a simple API gateway to access high-fidelity Indicators of Compromise (IOCs), curated from true positive security investigations across eSentire’s global customer base.

Key Points: 
  • eSentire Threat Intelligence provides mid-market and enterprise organizations with a simple API gateway to access high-fidelity Indicators of Compromise (IOCs), curated from true positive security investigations across eSentire’s global customer base.
  • - STIX Format for Easy Integration and Rich Context: eSentire Threat Intelligence leverages Structured Threat Information Expression (STIX™) format allowing for easy API integration across an organization’s firewalls, threat intelligence platform, email servers and endpoint agents.
  • “In today’s world of threat intelligence, more is not better,” confirms Ryan Westman, director, eSentire Threat Response Unit.
  • To learn more about eSentire Threat Intelligence and to take advantage of limited-time introductory pricing, visit here.

Stellar Cyber Recognizes DXC Technology as 2023 Asia Pacific GSI Partner of the Year

Retrieved on: 
Tuesday, March 19, 2024

Stellar Cyber, the innovator of Open XDR for security operations, announced DXC Technology as its 2023 Asia Pacific GSI Partner of the Year.

Key Points: 
  • Stellar Cyber, the innovator of Open XDR for security operations, announced DXC Technology as its 2023 Asia Pacific GSI Partner of the Year.
  • Since partnering with DXC, Stellar Cyber has seen significant growth in awareness and adoption of Open XDR throughout the Asia Pacific region.
  • DXC is a Fortune 500 IT service provider committed to delivering world-class services for its enterprise and government customers.
  • With DXC, we knew we had the right partner to deliver Open XDR effectively for customers in Asia Pacific, and we look forward to a long-lasting, mutually-productive relationship.”

Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand

Retrieved on: 
Monday, March 18, 2024

RESEARCH TRIANGLE PARK, N.C. and UXBRIDGE, England, March 18, 2024 /PRNewswire/ -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, and Norgine, a leading European specialist pharmaceutical company, today announced an exclusive licensing agreement under which Norgine will commercialize PEDMARQSI® in Europe, Australia and New Zealand. PEDMARQSI is the first and only approved therapy in the EU and U.K. for the prevention of ototoxicity (hearing loss) induced by cisplatin chemotherapy in patients 1 month to

Key Points: 
  • Norgine will be responsible for all commercialization activities in the licensed territories and will hold all marketing authorizations in the licensed territories.
  • It is estimated that more than 5,000 pediatric patients annually are eligible for platinum-based chemotherapy in Europe.
  • The studies compared PEDMARQSI plus cisplatin-based regimens to cisplatin-based regimens alone for the reduction of cisplatin-induced hearing loss in pediatric patients.
  • Moelis & Company LLC acted as financial advisor, and LaBarge Weinstein LLP acted as legal advisor to Fennec.